These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokinine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes. Ottonello L; Morone P; Dapino P; Dallegri F Blood; 1996 Jun; 87(12):5171-8. PubMed ID: 8652830 [TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors. Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: intervention of FcgammaRII (CD32), CD11b-CD18 integrins, and CD66b glycoproteins. Ottonello L; Epstein AL; Dapino P; Barbera P; Morone P; Dallegri F Blood; 1999 May; 93(10):3505-11. PubMed ID: 10233903 [TBL] [Abstract][Full Text] [Related]
6. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. Graziano RF; Fanger MW J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735 [TBL] [Abstract][Full Text] [Related]
7. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells. Wallgren A; Festin R; Gidlöf C; Dohlsten M; Kalland T; Tötterman TH Blood; 1993 Aug; 82(4):1230-8. PubMed ID: 8102559 [TBL] [Abstract][Full Text] [Related]
8. Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma. Kornacker M; Moldenhauer G; Herbst M; Weilguni E; Tita-Nwa F; Harter C; Hensel M; Ho AD Int J Cancer; 2006 Sep; 119(6):1377-82. PubMed ID: 16642465 [TBL] [Abstract][Full Text] [Related]
9. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32). Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020 [TBL] [Abstract][Full Text] [Related]
10. B-cell chronic lymphocytic leukaemia populations respond stochastically to combinations of growth signals in vitro. McManus AP; Desai ZR; Lavabre-Bertrand T Leuk Res; 1993 Jun; 17(6):477-81. PubMed ID: 8505846 [TBL] [Abstract][Full Text] [Related]
12. Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells. Klitgaard JL; Koefoed K; Geisler C; Gadeberg OV; Frank DA; Petersen J; Jurlander J; Pedersen MW Br J Haematol; 2013 Oct; 163(2):182-93. PubMed ID: 23927424 [TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma is unable to increase monocyte and neutrophil-mediated nonspecific cytotoxicity induced by immune complexes. Geffner JR; Minnucci F; Isturiz MA Immunol Lett; 1992 Jun; 33(1):21-5. PubMed ID: 1427988 [TBL] [Abstract][Full Text] [Related]
14. Effect of alemtuzumab on neoplastic B cells. Golay J; Manganini M; Rambaldi A; Introna M Haematologica; 2004 Dec; 89(12):1476-83. PubMed ID: 15590398 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum. Lefebvre ML; Krause SW; Salcedo M; Nardin A J Immunother; 2006; 29(4):388-97. PubMed ID: 16799334 [TBL] [Abstract][Full Text] [Related]
16. Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: stimulation by GM-CSF and role of Fc gamma -receptors. Ottonello L; Epstein AL; Mancini M; Tortolina G; Dapino P; Dallegri F Br J Cancer; 2001 Aug; 85(3):463-9. PubMed ID: 11487281 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture. Vyth-Dreese FA; de Vries JE Leuk Res; 1984; 8(1):1-14. PubMed ID: 6321859 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factor. O'Boyle KP; Colletti D; Mazurek C; Wang Y; Ray SK; Diamond B; Rosenblum MG; Epstein AL; Shochat D; Dutcher JP J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):221-30. PubMed ID: 8680650 [TBL] [Abstract][Full Text] [Related]
19. Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612. Pendurthi TK; Parker R; Schlom J; Primus FJ Int J Cancer; 1990 Dec; 46(6):1021-8. PubMed ID: 2123477 [TBL] [Abstract][Full Text] [Related]
20. Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii. Erbe DV; Pfefferkorn ER; Fanger MW J Immunol; 1991 May; 146(9):3145-51. PubMed ID: 1826707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]